Seelaus Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Seelaus Asset Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,833	Closed	-$280K	–	287
2021 Q4	$280K	Sell	1,833 -490	-21%	-$75.9K	0.15%	185
2021 Q3	$376K	Hold	2,323	–	–	0.22%	152
2021 Q2	$380K	Sell	2,323 -11	-0.5%	-$1.69K	0.22%	152
2021 Q1	$351K	Buy	2,334 +652	+39%	+$104K	0.23%	137
2020 Q4	$255K	Buy	+1,682	New	+$240K	0.19%	149

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Seelaus Asset Management's IBB Position: Q1 2022 in Review

Seelaus Asset Management sold out of iShares Biotechnology ETF (IBB) in Q1 2022, closing a stake of 1,833 shares — an estimated $280K sold.

Seelaus Asset Management first reported a position in IBB in Q4 2020 and held it in 5 quarters. The position peaked at $380K in Q2 2021. 897 funds tracked by Wall St. Rank hold IBB as of Q1 2022.

Seelaus Asset Management reported no remaining iShares Biotechnology ETF position as of Q1 2022 after selling out during the quarter.
Seelaus Asset Management sold 1,833 iShares Biotechnology ETF shares in Q1 2022, an estimated $280K.
Seelaus Asset Management first reported a position in iShares Biotechnology ETF in Q4 2020 and held it in 5 quarters.
Seelaus Asset Management's iShares Biotechnology ETF position peaked at $380K in Q2 2021.
897 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2022.

Based on Seelaus Asset Management's 13F filing for Q1 2022, filed 13 Apr 2022.